Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

0
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Category

Show more Refine

For: Laurindo LF, Laurindo LF, Rodrigues VD, Catharin VMCS, Simili OAG, Barboza GO, Catharin VCS, Sloan KP, Barbalho SM. Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review. Naunyn Schmiedebergs Arch Pharmacol 2025;398:165-177. [PMID: 39136737 DOI: 10.1007/s00210-024-03362-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2024] [Accepted: 08/06/2024] [Indexed: 02/02/2025]

For:	Laurindo LF, Laurindo LF, Rodrigues VD, Catharin VMCS, Simili OAG, Barboza GO, Catharin VCS, Sloan KP, Barbalho SM. Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review. Naunyn Schmiedebergs Arch Pharmacol 2025;398:165-177. [PMID: 39136737 DOI: 10.1007/s00210-024-03362-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2024] [Accepted: 08/06/2024] [Indexed: 02/02/2025]

No articles found.

(The first 100,000 artilces are displayed in RCA.)